Sanara MedTech Inc
Research Sanara MedTech Inc (SMTI) on Bullrun: market cap USD 318.74M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSMTI
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 318.74M
- Financial periodQ1 2026
- RevenueUSD 27.80M
- Net income-USD 33.58M
- Free cash flowUSD 3.35M
- Gross margin359.3%
Valuation Snapshot
latest market cap is USD 318.74M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 103.12M | USD 37.56M | USD 2.16M | 92.7% | -4.36 | USD 16.58M | USD 45.97M | USD 5.94M |
| FY2024 | USD 86.67M | USD 9.66M | -USD 229.63K | 90.6% | -1.14 | USD 15.88M | USD 30.69M | USD 39.40M |
| FY2023 | USD 64.99M | USD 4.30M | -USD 3.51M | 87.9% | -0.52 | USD 5.15M | USD 9.69M | USD 44.83M |
| FY2022 | USD 45.84M | -USD 7.94M | -USD 5.70M | 86.1% | -1 | USD 8.96M | USD 308.34K | USD 41.83M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 318.74M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 208.91M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 290.63M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 350.93M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 377.82M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 226.85M | n/a | n/a | n/a |
About Sanara MedTech Inc
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sanara MedTech Inc's market cap?
Sanara MedTech Inc's market capitalization is USD 318.74M.
What does Sanara MedTech Inc do?
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.